Hims & Hers is expanding its offerings through the Trybe Labs deal after it added compounded weight loss drugs.

Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...

After having massive success with off-brand weight-loss drugs, the millennial-focused telehealth company Hims & Hers (HIMS) ...

The Global Medical Blood Lancet Market is projected to reach USD 1,552.9 million by the end of 2024 and grow steadily towards an expected value of USD 3,682.8 million by 2033 with compound annual ...

Hims & Hers Health (HIMS) stock rocketed higher today after the telehealth platform operator announced plans to introduce ...

The Global Medical Blood Lancet Market is projected to reach USD 1,552.9 million by the end of 2024 and grow steadily towards an expected value of USD 3,682.8 million by 2033 with compound annual ...

Lifestyle changes and medicine for cardiovascular problems may help lower the risks of blood vessel damage and so keep ...

Oops—this story was an April Fool's Day prank! The pointy ears were the first indication that Star Trek Vulcan Mr. Spock was ...

In 5 to 10 per cent of people with high blood pressure, the condition is caused by tiny tumours in their adrenal glands that ...

A clinical research team from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), and international genetic researchers led a global research study using multi-omics analysis and ...

The Helmsley Charitable Trust’s T1D Exercise Initiative ( T1-DEXI) datasets provide baseline information on the glycemic ...